Basic Mobility and Balance Performance of Low Active Transfemoral Prosthesis Users With a Powered Prosthetic Knee
NCT ID: NCT04799145
Last Updated: 2026-01-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6 participants
INTERVENTIONAL
2021-02-05
2021-02-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT01147094
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT00791414
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT04773912
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT04786912
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT01773941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There were two scheduled study events. At the initial visit, the first study event, for each subject a researcher qualified to obtain informed consent seated the subject and proceeded as described in chapter 13.7 Informed consent in \[2\].
Prior to fitting the subject was asked to provide feedback on their prescribed prosthesis, by filling in a questionnaire and perform AMPro, LCI (modified), TUG test, 2MWT and other validation activities (stand to sit, sit to stand, level ground, stair and ramp walking), as applicable. The users were fitted within the standard methods of prosthetic fitting, alignment, introduction, training and walking on various terrain.
After initial fitting subjects carried out validation tasks (stand to sit, sit to stand tasks, level ground walking at different speeds, stair and ramp walking), stroop test (cognitive loading) and FSST on the investigational device, after which they answered an in-house questionnaire to provide feedback.
During the second event, subjects were fitted with the investigational device and asked to perform the TUG, 2MWT and any validation tasks that could not be completed at visit 1 on the investigational device due to time restraints or subject condition.
If for some reason all tasks could not be completed at visit 1 and 2 due to time restraints or subject condition, a third visit was added.
Subjects did not wear the device home between visits.
Statistical Considerations:
Outcomes were inspected for normality. If the data was deemed to have a normal distribution the hypothesis was tested using a two-tailed, paired t-test (Only hypothesis A and B). If data was deemed non-normal that hypothesis was tested using a Wilcoxon signed rank test. Significance level (alpha) will be set at 0.05.
Other endpoints and acceptance criteria were assessed with descriptive statistics only.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Investigational device
All subjects performed outcome measures on their prescribed knee and the investigational device for comparison.
Investigational device
Motorized microprocessor controlled prosthetic knee.
Prescribed device
Passive microprocessor controlled knee and mechanical knee
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Investigational device
Motorized microprocessor controlled prosthetic knee.
Prescribed device
Passive microprocessor controlled knee and mechanical knee
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cognitive ability to understand all instructions and questionnaires in the study;
* K1-K2 unilateral transfemoral amputees
* Allows for 37mm knee center height to dome of pyramid alignment
* Age ≥ 18 years
* Willing and able to participate in the study and follow the protocol
* Comfortable and stable socket fit (5 or over on the SFCS)
Exclusion Criteria
* Users aged \<18y
* Bilateral amputees
* Users with stump pain affecting their functional mobility
* Users with socket problems
* Users with co-morbidities in the contra-lateral limb, which significantly affect their functional mobility
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Össur Iceland ehf
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CII2020111613
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.